Streetbeat News

Revenues

AMRN

Amarin has reiterated that for FY24, it believes its current cash, investments, and other assets are adequate to support continued operations.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:06 am

DFIN

Donnelley Financial Solutions (NYSE:DFIN) reported Q2 earnings of $1.66 per share, beating the analyst estimate of $1.40. However, sales of $242.70 million missed the estimate of $244.62 million.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:05 am

BXP

BXP announced it signed approximately 1.3 million square feet of leases in Q2 2024 with an average lease term of 9 years, bringing total leasing activity for 2024 to around 2.2 million square feet.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:05 am

CHEF

The Chefs' Warehouse (NASDAQ:CHEF) reported Q2 earnings of $0.40 per share, beating the analyst estimate of $0.36. Sales were $954.70M, surpassing the $943.70M estimate. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:04 am

OPCH

Option Care Health reported Q2 2024 GAAP EPS of $0.30, beating the estimate of $0.28. Sales were $1.227 billion, surpassing the estimate of $1.170 billion.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:04 am

OSK

Oshkosh (NYSE:OSK) reported Q2 2024 adjusted EPS of $3.34, beating the estimate of $2.98. Sales were $2.850 billion, surpassing the $2.754 billion estimate and marking an 18.11% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:03 am

SMG

Scotts Miracle Gro (NYSE:SMG) reported Q3 2024 adjusted EPS of $2.31, beating the estimate of $1.93. Sales were $1.202 billion, surpassing the $1.198 billion estimate and showing a 7.42% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:03 am

BLCO

Bausch & Lomb reported Q2 2024 adjusted EPS of $0.13, beating the estimate of $0.12. Sales were $1.216 billion, surpassing the $1.170 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:03 am

AVNS

Avanos Medical (NYSE:AVNS) reported Q2 2024 earnings of $0.34 per share, beating the analyst estimate of $0.29. Sales were $171.7 million, also surpassing the $170.667 million estimate. This represents a 41.67% increase in EPS and a 1.36% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:03 am

MO

Altria Group (NYSE:MO) reported Q2 2024 adjusted EPS of $1.31, missing the analyst estimate of $1.34. Sales were $5.277 billion, also missing the estimate of $5.392 billion. Both EPS and sales figures were lower compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:02 am